QT Imaging Holdings, Inc.

Mr. Nasser C. Pirshafiey M.B.A.

Chief Product Officer

Dr. Bilal  Malik Ph.D.

Chief Science Officer

Mr. Anastas  Budagov

Chief Financial Officer

Dr. Raluca  Dinu Ph.D.

Chief Executive Officer & Director

Mr. Steve  Choate

Chief Operating Officer

QT Imaging Holdings, Inc. engages in the manufacturing, research, and development of automated breast imaging system for producing high-resolution transmission ultrasound images. It offers QT Ultrasound Breast Scanner that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the third year renewal of its five-year research grant from the National Institutes of Health (NIH)/National Cancer Institute (NCI). The study is a collaboration with the Department of Radiation Oncology, the Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toront.

QT Imaging Granted Renewal of NIH Sponsored Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce an amendment to its $10,000,000 convertible promissory note with YA II PN, Ltd. (the “Investor,” and such promissory note, the “Note”). On September 11, 2024, a trigger event associated with the share price of the company occurred under the terms of the Note. As a result, the company m.

QT Imaging Holdings Announces Favorable Amendment of Convertible Promissory Note

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce participation in the International Ultrasonics Symposium (IUS), an IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society conference, held in Taipei, Taiwan, on September 22-26, 2024. Dr. James Wiskin will represent QTI in the Medical Imaging subsection. The presentation focuss.

QT Imaging Holdings Announces Participation in the IEEE International Ultrasonics Symposium, in Taipei, Taiwan

QT Imaging Holdings (NASDAQ: QTI ) just reported results for the second quarter of 2024. QT Imaging Holdings reported earnings per share of -30 cents.

QTI Stock Earnings: QT Imaging Holdings Reported Results for Q2 2024

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment. University of Oklahoma (OU) is home to the National Cancer Institute (NCI) designated OU Health Steph.

QT Imaging Holdings, Inc.QTI

QT Imaging Holdings, Inc.
QTI